DK2134712T3 - Aspartat af 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro(3, 4)oct-6-yl)-4-oxo-1,4-dihydro-(1,8) naphthyridin-3-karboxylsyre, fremgangsmåde til fremstilling af samme og antimikrobielt farmaceutisk sammensætning omfattende samme - Google Patents
Aspartat af 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro(3, 4)oct-6-yl)-4-oxo-1,4-dihydro-(1,8) naphthyridin-3-karboxylsyre, fremgangsmåde til fremstilling af samme og antimikrobielt farmaceutisk sammensætning omfattende sammeInfo
- Publication number
- DK2134712T3 DK2134712T3 DK08741351.4T DK08741351T DK2134712T3 DK 2134712 T3 DK2134712 T3 DK 2134712T3 DK 08741351 T DK08741351 T DK 08741351T DK 2134712 T3 DK2134712 T3 DK 2134712T3
- Authority
- DK
- Denmark
- Prior art keywords
- same
- methoxyimino
- naphthyridine
- diaza
- aspartate
- Prior art date
Links
- ZNPOCLHDJCAZAH-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diazaspiro[3.4]octan-6-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid Chemical compound CON=C1CN(C=2C(=CC=3C(=O)C(C(O)=O)=CN(C=3N=2)C2CC2)F)CC11CNC1 ZNPOCLHDJCAZAH-UHFFFAOYSA-N 0.000 title 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 title 1
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 229940009098 aspartate Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20070036574 | 2007-04-13 | ||
| PCT/KR2008/002106 WO2008127060A1 (en) | 2007-04-13 | 2008-04-14 | Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2134712T3 true DK2134712T3 (da) | 2013-11-18 |
Family
ID=39864109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08741351.4T DK2134712T3 (da) | 2007-04-13 | 2008-04-14 | Aspartat af 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro(3, 4)oct-6-yl)-4-oxo-1,4-dihydro-(1,8) naphthyridin-3-karboxylsyre, fremgangsmåde til fremstilling af samme og antimikrobielt farmaceutisk sammensætning omfattende samme |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8324238B2 (da) |
| EP (1) | EP2134712B1 (da) |
| JP (1) | JP5194105B2 (da) |
| KR (1) | KR100953271B1 (da) |
| CN (1) | CN101679416B (da) |
| AU (1) | AU2008239966C1 (da) |
| BR (1) | BRPI0810192C1 (da) |
| CA (1) | CA2683939C (da) |
| CO (1) | CO6251358A2 (da) |
| DK (1) | DK2134712T3 (da) |
| EC (1) | ECSP099736A (da) |
| ES (1) | ES2436140T3 (da) |
| HK (1) | HK1133881A1 (da) |
| MX (1) | MX2009011063A (da) |
| PL (1) | PL2134712T3 (da) |
| PT (1) | PT2134712E (da) |
| WO (1) | WO2008127060A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080109108A (ko) | 2007-06-12 | 2008-12-17 | (주)엘티엠에이피 | 휴대단말기용 스텝 힌지 |
| KR101468659B1 (ko) * | 2009-07-27 | 2014-12-05 | 주식회사 아리바이오 | Ｒ-7-(3-아미노메틸-4-메톡시이미노-3-메틸-피롤리딘-1-일)-1-시클로프로필-6-플루오로-4-옥소-1,4-디히드로-[1,8]나프티리딘-3-카르복실산 ｌ-아스파르트산염, 이의 제조방법 및 이를 포함하는 항균용 약학적 조성물 |
| KR101646324B1 (ko) * | 2014-03-04 | 2016-08-05 | 동화약품주식회사 | 1-시클로프로필-6-플루오로-7-(8-메톡시이미노-2,6-디아자-스피로[3,4]옥트-6-일)-4-옥소-1,4-디히드로-[1,8]나프티리딘-3-카르복실산 디-아스파르트산염의 수화물 및 이를 포함하는 항균활성 조성물 |
| CN103922987B (zh) * | 2014-05-04 | 2016-09-28 | 苏州天马精细化学品股份有限公司 | 一种扎布沙星中间体及其合成方法 |
| KR102213991B1 (ko) * | 2014-05-20 | 2021-02-09 | 동화약품주식회사 | 개선된 자보플록사신의 제조방법 |
| CN114894924B (zh) * | 2022-04-21 | 2024-06-21 | 徐州医科大学 | 一种通过非衍生化gc-ms同时测定人血浆中4种抗癫痫药物的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8304117A1 (es) | 1981-06-11 | 1983-02-16 | Warner Lambert Co | "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina". |
| JPS58966A (ja) * | 1981-06-11 | 1983-01-06 | ワ−ナ−−ランバ−ト・コンパニ− | 抗菌性ナフチリジンおよびキノリン化合物の塩 |
| DE3537761A1 (de) * | 1985-10-24 | 1987-04-30 | Bayer Ag | Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure |
| KR960000223A (ko) * | 1994-06-08 | 1996-01-25 | 김정순 | 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법 |
| WO1999000393A1 (en) | 1997-06-26 | 1999-01-07 | Dong Wha Pharmaceutical Industrial Co., Ltd. | Quinolone carboxylic acid derivatives |
| DE60033830T2 (de) * | 1999-10-04 | 2007-11-15 | John Harrow Carter | Pharmazeutische zusammensetzung, die kupfer, salicylsäure und vitamin c enthält |
| PT1492789E (pt) | 2002-04-08 | 2006-09-29 | Pfizer | Derivados de tropano como moduladores ccr5 |
-
2008
- 2008-04-14 CA CA2683939A patent/CA2683939C/en active Active
- 2008-04-14 AU AU2008239966A patent/AU2008239966C1/en active Active
- 2008-04-14 MX MX2009011063A patent/MX2009011063A/es active IP Right Grant
- 2008-04-14 KR KR1020080034411A patent/KR100953271B1/ko active Protection Beyond IP Right Term
- 2008-04-14 JP JP2010502952A patent/JP5194105B2/ja active Active
- 2008-04-14 PL PL08741351T patent/PL2134712T3/pl unknown
- 2008-04-14 CN CN2008800119780A patent/CN101679416B/zh active Active
- 2008-04-14 ES ES08741351T patent/ES2436140T3/es active Active
- 2008-04-14 DK DK08741351.4T patent/DK2134712T3/da active
- 2008-04-14 WO PCT/KR2008/002106 patent/WO2008127060A1/en active Application Filing
- 2008-04-14 BR BRPI0810192A patent/BRPI0810192C1/pt not_active IP Right Cessation
- 2008-04-14 EP EP08741351.4A patent/EP2134712B1/en active Active
- 2008-04-14 PT PT87413514T patent/PT2134712E/pt unknown
- 2008-04-14 US US12/595,606 patent/US8324238B2/en active Active
-
2009
- 2009-10-27 CO CO09120908A patent/CO6251358A2/es not_active Application Discontinuation
- 2009-11-13 EC EC2009009736A patent/ECSP099736A/es unknown
- 2009-12-29 HK HK09112267.2A patent/HK1133881A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008239966B2 (en) | 2011-11-10 |
| BRPI0810192B8 (pt) | 2019-09-10 |
| EP2134712A4 (en) | 2011-07-27 |
| EP2134712B1 (en) | 2013-08-21 |
| KR20080092893A (ko) | 2008-10-16 |
| US20100184795A1 (en) | 2010-07-22 |
| PL2134712T3 (pl) | 2014-01-31 |
| BRPI0810192C1 (pt) | 2021-05-25 |
| CA2683939A1 (en) | 2008-10-23 |
| ES2436140T3 (es) | 2013-12-27 |
| CN101679416A (zh) | 2010-03-24 |
| CA2683939C (en) | 2012-06-19 |
| CN101679416B (zh) | 2012-06-27 |
| AU2008239966A1 (en) | 2008-10-23 |
| MX2009011063A (es) | 2009-10-30 |
| BRPI0810192A2 (pt) | 2014-12-30 |
| HK1133881A1 (da) | 2010-04-09 |
| BRPI0810192B1 (pt) | 2019-09-03 |
| PT2134712E (pt) | 2013-11-26 |
| KR100953271B1 (ko) | 2010-04-16 |
| AU2008239966C1 (en) | 2012-03-29 |
| WO2008127060A1 (en) | 2008-10-23 |
| ECSP099736A (es) | 2010-02-26 |
| US8324238B2 (en) | 2012-12-04 |
| JP5194105B2 (ja) | 2013-05-08 |
| JP2010523649A (ja) | 2010-07-15 |
| EP2134712A1 (en) | 2009-12-23 |
| CO6251358A2 (es) | 2011-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1928875T3 (pl) | 2-Amino-7,8-dihydro-6H-pirydo(4,3-d)pirymidyn-5-ony, sposoby ich otrzymywania oraz kompozycje farmaceutyczne je zawierające | |
| CA2672094C (en) | Methods and apparatus for identifying subject matter in view data | |
| WO2009067686A3 (en) | Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof | |
| IL221952A (en) | Annotations 2, 3-Dihydro-1h - Indene-1-Il-7,2- Diazaspiro [5.3] Noonan and Pharmaceuticals Containing Them | |
| IL204844A (en) | Coinolone analogues, pharmaceuticals containing them and their uses | |
| IL198289A (en) | Processed dihydropyrazolones, processes for their preparation, medicinal preparations containing them and their use in the preparation of medicinal preparations | |
| IL203099A (en) | Acidic Acid (s) - Optically active aryloxypropionic, methods of preparation and herbicide-containing preparations | |
| IL185353A0 (en) | Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof | |
| IL178425A0 (en) | Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| WO2010117738A3 (en) | Solid state forms of sitagliptin salts | |
| PT2364983E (pt) | Novo derivado tricíclico ou seus sais farmaceuticamente aceitáveis, seu método de preparação, e composição farmacêutica que o contém | |
| DK2134712T3 (da) | Aspartat af 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro(3, 4)oct-6-yl)-4-oxo-1,4-dihydro-(1,8) naphthyridin-3-karboxylsyre, fremgangsmåde til fremstilling af samme og antimikrobielt farmaceutisk sammensætning omfattende samme | |
| EP1916251A4 (en) | ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| EP2201011A4 (en) | NEW COMPOUNDS WITH INDAZOUS OUTS, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| ZA200709331B (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
| SI1928875T1 (sl) | 2-amino-7,8-dihidro-6H-pirido(4,3-d)pirimidin-5-oni, postopek za njihovo pripravo in farmacevtski sestavki, ki vsebujejo le-te | |
| PL2231598T3 (pl) | Nowe pochodne diazeniodiolanów, sposób ich wytwarzania i kompozycje farmaceutyczne je zawierające | |
| EP2212325A4 (en) | 2-ARYLMETHYLAZETIDINCARBAPENEM-3-CARBOXYLENE DERTERIVATE OR SALT, METHOD FOR THE PRODUCTION THEREOF AND THEREOF COMPRISING PHARMACEUTICAL COMPOSITION | |
| WO2007087026A3 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
| IL199078A (en) | Converted quinoline derivatives, pharmaceutical preparations, combinations and products containing them, their uses and processes for their preparation | |
| WO2008070354A3 (en) | 5- and 6- substituted benzimidazole thiophene compounds | |
| TWI350755B (en) | New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid | |
| IL191992A (en) | Manicured cyclic compounds, including pharmaceutical preparations, processes for their preparation and uses | |
| ZA200806399B (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
| IL176870A0 (en) | Solid forms of montelukast acid, pharmaceutical compositions containing the same and processes for the preparation thereof |